Gain-framed Messages and NRT for Lung Cancer Screening Patients
Status:
Recruiting
Trial end date:
2022-12-01
Target enrollment:
Participant gender:
Summary
This research is a randomized smoking cessation trial conducted within and specifically
personalized for lung cancer screening patients presenting to a lung screening clinic. Novel
tobacco treatments for this population are critically needed, given the growing population of
lung screening patients, which will grow dramatically now that lung screening is an approved
CMS benefit. In the proposed study, we will test a gain-framed messaging intervention
specifically designed for lung screening patients (vs. unframed messaging), as well as
evaluating NRT sampling (vs. no medication) at 2 study sites. Our project is designed to be
translational (in that it can be transferable from our controlled efficacy study to other
lung screening programs).